AGITATION ASSOCIATED WITH ALZHEIMER'S DEMENTIA

Clinical trials for AGITATION ASSOCIATED WITH ALZHEIMER'S DEMENTIA explained in plain language.

Never miss a new study

Get alerted when new AGITATION ASSOCIATED WITH ALZHEIMER'S DEMENTIA trials appear

Sign up with your email to follow new studies for AGITATION ASSOCIATED WITH ALZHEIMER'S DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for calming Alzheimer's agitation

Symptom relief Recruiting now

This study is testing whether an investigational drug called ITI-1284 can safely reduce agitation in people with Alzheimer's dementia. About 320 participants will be randomly assigned to receive either the drug or a placebo for 12 weeks. The main goal is to see if the drug helps …

Matched conditions: AGITATION ASSOCIATED WITH ALZHEIMER'S DEMENTIA

Phase: PHASE2 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Symptom relief

Last updated Mar 27, 2026 12:39 UTC

AGITATION ASSOCIATED WITH ALZHEIMER'S DEMENTIA

Get alerted when new AGITATION ASSOCIATED WITH ALZHEIMER'S DEMENTIA trials appear

New hope for calming Alzheimer's agitation